Will Intravascular OCT Shed Light on Vascular Biology?

JACC: Cardiovascular Imaging

Volumn 3, Issue 1, 2010, Pages 85-87

  Bezerra, Hiram G ^a   Costa, Marco A ^a  

^a UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

Author keywords

coronary; optical coherence tomography; stent

Indexed keywords

ACCURACY; ACUTE HEART INFARCTION; ARTERY INTIMA PROLIFERATION; ARTIFACT; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; CORONARY ARTERY BLOOD FLOW; CORONARY STENT; DRUG ELUTING STENT; EDITORIAL; HEART MOVEMENT; HISTOPATHOLOGY; HUMAN; IMAGE DISPLAY; IMAGE PROCESSING; IMAGE QUALITY; NONHUMAN; OPTICAL COHERENCE TOMOGRAPHY; PRIORITY JOURNAL; PROGNOSIS; RISK BENEFIT ANALYSIS; TREATMENT FAILURE;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ANIMALS; CORONARY VESSELS; DRUG-ELUTING STENTS; HUMANS; PREDICTIVE VALUE OF TESTS; PROSTHESIS DESIGN; REPRODUCIBILITY OF RESULTS; THROMBOSIS; TIME FACTORS; TOMOGRAPHY, OPTICAL COHERENCE; TUNICA INTIMA;

EID: 73649083025     PISSN: 1936878X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcmg.2009.10.007     Document Type: Editorial

References (25)

1. Virmani R., Guagliumi G., Farb A., et al. Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent: should we be cautious?. Circulation 109 (2004) 701-705
2. Sousa J.E., Costa M.A., Farb A., et al. Images in cardiovascular medicine. Vascular healing 4 years after the implantation of sirolimus-eluting stent in humans: a histopathological examination. Circulation 110 (2004) e5-e6
3. Serruys P.W., Ormiston J.A., Sianos G., et al. Actinomycin-eluting stent for coronary revascularization: a randomized feasibility and safety study: the ACTION trial. J Am Coll Cardiol 44 (2004) 1363-1367
4. Murata A., Wallace-Bradley D., Tellez A., et al. Accuracy of optical coherence tomography in the evaluation of neointimal coverage after stent implantation. J Am Coll Cardiol Img 3 (2010) 76-84
5. Prati F., Zimarino M., Stabile E., et al. Does optical coherence tomography identify arterial healing after stenting?. An in vivo comparison with histology, in a rabbit carotid model. Heart 94 (2008) 217-221
6. Rippstein P., Black M.K., Boivin M., et al. Comparison of processing and sectioning methodologies for arteries containing metallic stents. J Histochem Cytochem 54 (2006) 673-681
7. Finn A.V., Joner M., Nakazawa G., et al. Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization. Circulation 115 (2007) 2435-2441
8. Finn A.V., Nakazawa G., Kolodgie F., and Virmani R. Drug eluting or bare metal stent for acute myocardial infarction: an issue of safety?. Eur Heart J 30 (2009) 1828-1830
9. Brar S.S., Leon M.B., Stone G.W., et al. Use of drug-eluting stents in acute myocardial infarction: a systematic review and meta-analysis. J Am Coll Cardiol 53 (2009) 1677-1689
10. Nakazawa G., Finn A.V., Joner M., et al. Delayed arterial healing and increased late stent thrombosis at culprit sites after drug-eluting stent placement for acute myocardial infarction patients: an autopsy study. Circulation 118 (2008) 1138-1145
11. Guagliumi G, Sirbu V, Bezerra HG, et al. Six-month strut coverage and vessel wall response of the zotralimus eluting stent compared to driver bare metal stent implanted in AMI. A prospective, randomized, controlled, study performed with optical coherence tomography. Paper presented at: Transcatheter Cardiovascular Therapeutics Annual Meeting; September 2009; San Francisco, CA.
12. Guagliumi G., Sirbu V., Costa M.A., et al. Long-term strut coverage of paclitaxel eluting stents compared with bare-metal stents implanted during primary PCI in acute myocardial infarction: a prospective, randomized, controlled study performed with optical coherence tomography. Circulation 118 (2008) 2315 HORIZONS-OCT (abstr)
13. Bezerra HG, Guagliumi G, Kyono H, et al. Determining the optimal cross-sectional analysis interval for OCT assessment of coronary stenting. Paper presented at: American Heart Association Scientific Session; November 2009; Orlando, FL.
14. Stone G. Two-year follow-up from a prospective, randomized trial of heparin plus glycoprotein IIb/IIIa inhibitors vs. bivalirudin and paclitaxel-eluting vs. bare-metal stents in STEMI. Paper presented at: Transcatheter Cardiovascular Therapeutics Annual Meeting; September 2009; San Francisco, CA.
15. Sawada T., Shite J., Shinke T., et al. Very late thrombosis of sirolimus-eluting stent due to late malapposition: serial observations with optical coherence tomography. J Cardiol 52 (2008) 290-295
16. Rosenthal N., Guagliumi G., Sirbu V., et al. Comparison of intravascular ultrasound and optical coherence tomography for the evaluation of stent segment malapposition (abstr). J Am Coll Cardiol 53 Suppl A (2009) 22A
17. Hassan A.K., Bergheanu S.C., Stijnen T., et al. Late stent malapposition risk is higher after drug-eluting stent compared with bare-metal stent implantation and associates with late stent thrombosis. Eur Heart J (2009 Jan 21) [E-pub ahead of print]
18. Guagliumi G, Musumeci G, Sirbu V, et al. A prospective, randomized, controlled study using optical coherence tomography to evaluate strut coverage of sirolimus-, paclitaxel-, and zotarolimus-eluting coronary stents in long lesions requiring overlapping. Paper presented at: Transcatheter Cardiovascular Therapeutics Annual Meeting; October 2008; Washington, DC.
19. Matsumoto D., Shite J., Shinke T., et al. Neointimal coverage of sirolimus-eluting stents at 6-month follow-up: evaluated by optical coherence tomography. Eur Heart J 28 (2007) 961-967
20. Motreff P., Souteyrand G., Levesque S., et al. Comparative analysis of neointimal coverage with paclitaxel and zotarolimus drug-eluting stents, using optical coherence tomography 6 months after implantation. Arch Cardiovasc Dis 102 (2009) 617-624
21. Gonzalo N., Barlis P., Serruys P.W., et al. Incomplete stent apposition and delayed tissue coverage are more frequent in drug-eluting stents implanted during primary percutaneous coronary intervention for ST-segment elevation myocardial infarction than in drug-eluting stents implanted for stable/unstable angina: insights from optical coherence tomography. J Am Coll Cardiol Intv 2 (2009) 445-452
22. Kim J.S., Fan C., Choi D., et al. Different patterns of neointimal coverage between acute coronary syndrome and stable angina after various types of drug-eluting stents implantation; 9-month follow-up optical coherence tomography study. Int J Cardiol (2009 Aug 24) [E-pub ahead of print]
23. Kubo T., Imanishi T., Kitabata H., et al. Comparison of vascular response after sirolimus-eluting stent implantation between patients with unstable and stable angina pectoris: a serial optical coherence tomography study. J Am Coll Cardiol Img 1 (2008) 475-484
24. Nguyen M.S., Salvado O., Roy D., et al. Ex vivo characterization of human atherosclerotic iliac plaque components using cryo-imaging. J Microsc 232 (2008) 432-441
25. Gawaz M., Langer H., and May A.E. Platelets in inflammation and atherogenesis. J Clin Invest 115 (2005) 3378-3384